What are the key considerations for anticoagulant therapy in patients with valvular atrial fibrillation, and how do they differ from non-valvular cases?
Home/Risk Differences
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.